Almac settles into Singapore with eyes on Asian expansion

Contract drug developer Almac has opened a new shop in Singapore, a facility that will serve as the company's Asian headquarters as it plots more investments in the region. Almac's outpost will focus on trial supplies, handling packaging, distribution and consultation for drugmakers in Asia. Singapore's Health Sciences Authority completed its inspection of the facility last week, clearing Almac to get rolling. Release

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.